We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection

By LabMedica International staff writers
Posted on 08 Apr 2025
Print article
Image: Pictorial representation of the working principle of a functionalized Carbon Dots CDs and EB based Func sensor (Photo courtesy of Toppari/University of Jyväskylä)
Image: Pictorial representation of the working principle of a functionalized Carbon Dots CDs and EB based Func sensor (Photo courtesy of Toppari/University of Jyväskylä)

Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are effective, they often lack the ability to provide spatiotemporal data on the release of viral genome material. In a significant breakthrough, researchers have developed a novel, label-free ratiometric fluorosensor that selectively and sensitively detects enteroviral RNA. This advancement paves the way for even more efficient detection methods and highlights the importance of interdisciplinary collaboration in addressing global health challenges.

Fluorescent nanoparticles have become powerful tools in bioanalyte sensing, with carbon dots (CDs) leading the charge due to their ease of synthesis, remarkable photostability, tunable photoluminescence, excellent solubility in water, biocompatibility, and versatile surface functionalities for ligand conjugation. These properties make CDs a transformative force in biosensing. At the Nanoscience Center (NSC) at the University of Jyväskylä (Jyväskylä, Finland), researchers have developed an enhanced ratiometric fluorosensor by functionalizing CDs with a Probe (a single-stranded complementary oligonucleotide fragment) and ethidium bromide (EB) for detecting enteroviral RNA. This effort, combining expertise in biology, chemistry, and physics, represents a significant advancement in viral detection technology.

The newly developed Functionalized Sensor (Func Sensor), where the CDs are covalently bonded with the probe, outperforms the traditional Non-Functionalized Sensor (Non-Func Sensor), which is a simple mix of CDs, the probe, and EB. In both sensor types, the target DNA enhances EB fluorescence upon hybridizing with the probe, while the CDs' fluorescence changes slightly due to electron transfer, enabling ratiometric detection. The Non-Func Sensor showed lower sensitivity to target DNA and was ineffective with actual enteroviral RNA samples. In contrast, the Func Sensor demonstrated much higher sensitivity to both DNA and real viral RNA, showing improved selectivity. The improved performance of the Func Sensor is attributed to enhanced charge transfer facilitated by the covalent functionalization of the CDs.

The proof-of-principle study, published in CARBON, emphasizes the significance of covalently immobilizing the probe to improve electron transfer between the CDs and EB, thereby enhancing performance. This research also demonstrates the Func Sensor’s suitability for practical applications in rapid, real-time, and precise in situ detection of viral RNA. Specifically, the study shows that the Func Sensor can detect enteroviral RNA release from the capsid in real time in vitro. This capability positions the Func Sensor as a novel platform for detecting viral RNA during infection, offering a critical advancement in real-time viral RNA detection. The team’s pioneering work not only provides a new method for viral RNA detection but also contributes valuable insights into charge transfer mechanisms between fluorophores. Building on this success, the team is now working to improve the system’s robustness by replacing the potentially harmful ethidium bromide with safer, less cytotoxic, or biocompatible dyes, further enhancing the safety and effectiveness of in vivo viral RNA detection.

Related Links:
University of Jyväskylä

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.